{"uid":"2e2b174ff170737a","name":"TEST-SPO-116378.01","historyId":"METTA-WAM-ISSUE-116:METTA-WAM-ISSUE-116#TEST-SPO-116378.01","time":{"start":1731711806000,"stop":1731711854376,"duration":48376},"status":"passed","flaky":false,"newFailed":false,"newBroken":false,"newPassed":false,"retriesCount":0,"retriesStatusChange":false,"beforeStages":[],"testStage":{"steps":[{"name":"<![CDATA[","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"<a href=\"https://trueagi-io.github.io/metta-wam/reports/tests_output/baseline-compat/tests/baseline_compat/anti-regression/issues/metta-wam-issue-116/test_spo_116378.metta.0_failed.html#METTA-WAM-ISSUE-116.TEST-SPO-116378.01\">Test Report</a>","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Assertion: (assertEqualToResult (match &hald116378 (Doxorubicin $p $o) (Doxorubicin $p $o)))","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Expected: ((Doxorubicin needed Cardiotoxicity) (Doxorubicin treat Rituximab) (Doxorubicin prolong Neoplasms) (Doxorubicin show Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin show Neoplasms) (Doxorubicin show Glioma) (Doxorubicin exhibit Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin exhibit Neoplasms) (Doxorubicin accumulate Brain_Neoplasms) (Doxorubicin monitor Neoplasms) (Doxorubicin sever Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin given Hemangiosarcoma) (Doxorubicin differ Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin elevated Trastuzum...(3194)","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Actual: ((Doxorubicin stratify Liposarcoma) (Doxorubicin associated MIR375) (Doxorubicin elevated Trastuzumab) (Doxorubicin include Trastuzumab) (Doxorubicin associated Cardiotoxicity) (Doxorubicin accepted 'Lymphoma,_B-Cell') (Doxorubicin represent Breast_Neoplasms) (Doxorubicin combine Breast_Neoplasms) (Doxorubicin fit Breast_Neoplasms) (Doxorubicin lead Death) (Doxorubicin cause Cardiotoxicity) (Doxorubicin stimulate Ischemia) (Doxorubicin induce CDKN2A) (Doxorubicin affect Cardiomyopathies) (Doxorubicin evaluate CAT) (Doxorubicin evaluate GSR) (Doxorubicin evaluate Lipid_Peroxides) (Doxorubicin e...(3194)","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"]]>","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false}],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":7,"attachmentsCount":0,"hasContent":true,"attachmentStep":false},"afterStages":[],"labels":[{"name":"resultFormat","value":"junit"},{"name":"suite","value":"METTA-WAM-ISSUE-116"},{"name":"testClass","value":"METTA-WAM-ISSUE-116"},{"name":"package","value":"METTA-WAM-ISSUE-116"}],"parameters":[],"links":[],"hidden":false,"retry":false,"extra":{"severity":"normal","retries":[],"categories":[],"history":{"statistic":{"failed":0,"broken":0,"skipped":0,"passed":38,"unknown":0,"total":38},"items":[{"uid":"54851f41cd89fb3c","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/502//#testresult/54851f41cd89fb3c","status":"passed","time":{"start":1731707812000,"stop":1731707860537,"duration":48537}},{"uid":"a80fe97a1ef3b394","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/501//#testresult/a80fe97a1ef3b394","status":"passed","time":{"start":1731707116000,"stop":1731707163891,"duration":47891}},{"uid":"48aa48a5297a0d3d","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/498//#testresult/48aa48a5297a0d3d","status":"passed","time":{"start":1731616405000,"stop":1731616452648,"duration":47648}},{"uid":"3689ae44a96833a0","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/499//#testresult/3689ae44a96833a0","status":"passed","time":{"start":1731616461000,"stop":1731616509340,"duration":48340}},{"uid":"8012458edf52c76e","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/497//#testresult/8012458edf52c76e","status":"passed","time":{"start":1731608327000,"stop":1731608375068,"duration":48068}},{"uid":"e7257efd077b869e","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/496//#testresult/e7257efd077b869e","status":"passed","time":{"start":1731549965000,"stop":1731550013410,"duration":48410}},{"uid":"da3a6319fc1b796b","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/494//#testresult/da3a6319fc1b796b","status":"passed","time":{"start":1731538621000,"stop":1731538669054,"duration":48054}},{"uid":"755ac01fd1a2b6e5","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/493//#testresult/755ac01fd1a2b6e5","status":"passed","time":{"start":1731538469000,"stop":1731538516463,"duration":47463}},{"uid":"6f30d3d4515425f4","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/492//#testresult/6f30d3d4515425f4","status":"passed","time":{"start":1731472385000,"stop":1731472433234,"duration":48234}},{"uid":"83f95b634e481a19","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/491//#testresult/83f95b634e481a19","status":"passed","time":{"start":1731471822000,"stop":1731471870604,"duration":48604}},{"uid":"62214b61668348ac","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/489//#testresult/62214b61668348ac","status":"passed","time":{"start":1731440836000,"stop":1731440884796,"duration":48796}},{"uid":"14e8bacae9418821","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/488//#testresult/14e8bacae9418821","status":"passed","time":{"start":1731436993000,"stop":1731437040606,"duration":47606}},{"uid":"d3f6e841f3cd5dfd","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/487//#testresult/d3f6e841f3cd5dfd","status":"passed","time":{"start":1731395807000,"stop":1731395855177,"duration":48177}},{"uid":"131ac9c004ccf3de","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/486//#testresult/131ac9c004ccf3de","status":"passed","time":{"start":1731395760000,"stop":1731395807934,"duration":47934}},{"uid":"eacd0710894c426c","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/484//#testresult/eacd0710894c426c","status":"passed","time":{"start":1731327080000,"stop":1731327127756,"duration":47756}},{"uid":"e66c4c750b30cdd9","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/483//#testresult/e66c4c750b30cdd9","status":"passed","time":{"start":1731324586000,"stop":1731324633719,"duration":47719}},{"uid":"ce6d124cd70ac740","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/479//#testresult/ce6d124cd70ac740","status":"passed","time":{"start":1731092585000,"stop":1731092633690,"duration":48690}},{"uid":"80026b97de7bfb05","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/478//#testresult/80026b97de7bfb05","status":"passed","time":{"start":1731088957000,"stop":1731089004414,"duration":47414}},{"uid":"abebd6930db65e59","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/477//#testresult/abebd6930db65e59","status":"passed","time":{"start":1731087852000,"stop":1731087899505,"duration":47505}},{"uid":"b7b38c99a787626d","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/476//#testresult/b7b38c99a787626d","status":"passed","time":{"start":1731087440000,"stop":1731087488612,"duration":48612}}]},"tags":[]},"source":"2e2b174ff170737a.json","parameterValues":[]}